Helixgate https://validator.w3.org/feed/docs/rss2.html STAT+: Why conversations around health AI may be evolving beyond hype Home Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA STAT+: Hair-raising trial results, and Servier’s M&A wishlist Genomics Pioneer and Life Sciences Entrepreneur J. Craig Venter Dies at 79 Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks FDA’s oncology advisors vote against ‘new paradigm’ in AstraZeneca trial Advanced Neural Probes Reveal Predictable Patterns in Epileptic Brain Activity Court dismisses part of Lilly lawsuit against Empower, some claims can proceed STAT+: As artificial intelligence show off diagnostic chops, scientists reckon with the way forward Lilly’s weight loss pill reaches brand new patients, even without full-court marketing press Merck still sees ‘compelling’ outlook for Terns leukemia drug UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy Pathogenic Bacterium Rewires Gut Environment to Colonize and Cause Disease Avalyn’s upsized IPO; Alector ends another study in GSK partnership FDA pauses schizophrenia trial after patient death  XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise STAT+: Cigna will exit ACA individual markets next year, adding to tumult for patients UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel What we heard at a health tech conference in Boston BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout AstraZeneca’s camizestrant ambitions stumble as FDA panel rejects novel oral SERD proposal STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more CVS’ healthcare delivery chief eyes potential in clinical AI Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences Smog from wildfires increasingly harmful, data show Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study Lack of specifics on obesity pill sales hover over Lilly’s first quarter Novartis unveils North Carolina factory as final new build in $23B US expansion STAT+: What does Akeso’s primo plenary spot say about its survival data? STAT+: New obesity tool aims to predict risk of 18 serious complications What makes life science angel investment work? 6 biotechs that called it quits in Q1 7 companies hiring in North Carolina now Tackling drug resistance must become biotech’s next frontier FDA’s end to 9-month adcomm drought a ‘narrow restart’ Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs AstraZeneca plucks preclinical EGFR degrader from Pinetree for $25M STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive AbbVie faces questions about Skyrizi competition from J&J AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate “Click Clotting” Technique Rapidly Creates Stronger Blood Clots Avalyn, in pursuit of better lung drugs, banks $300M in an IPO Restoring Vision with Stem Cell–Derived Retinal Cells by Overcoming ILM Barrier HHS appeals ruling that stalled many of Kennedy’s vaccine policy changes STRAIGHT-IN Dual: a platform for dual single-copy integrations of DNA payloads and gene circuits into human induced pluripotent stem cells Tracing the rise of biomedical foundation models